Transmembrane signaling by receptor tyrosine kinases (RTKs) entails ligand-mediated dimerization and structural rearrangement of the extracellular domains. RTK activation also depends on the specific orientation of the transmembrane domain (TMD) helices, as suggested by pathogenic, constitutively active RTK mutants. Such mutant TMDs carry polar amino acids promoting stable transmembrane helix dimerization, which is essential for kinase activation. We investigated the effect of polar amino acids introduced into the TMD of vascular endothelial growth factor receptor 2, regulating blood vessel homeostasis. Two mutants showed constitutive kinase activity, suggesting that precise TMD orientation is mandatory for kinase activation. Nuclear magnetic resonance spectroscopy revealed that TMD helices in activated constructs were rotated by 180 relative to the interface of the wild-type conformation, confirming that ligand-mediated receptor activation indeed results from transmembrane helix rearrangement. A molecular dynamics simulation confirmed the transmembrane helix arrangement of wild-type and mutant TMDs revealed by nuclear magnetic resonance spectroscopy.
SUMMARY
Transmembrane signaling by receptor tyrosine kinases (RTKs) entails ligand-mediated dimerization and structural rearrangement of the extracellular domains. RTK activation also depends on the specific orientation of the transmembrane domain (TMD) helices, as suggested by pathogenic, constitutively active RTK mutants. Such mutant TMDs carry polar amino acids promoting stable transmembrane helix dimerization, which is essential for kinase activation. We investigated the effect of polar amino acids introduced into the TMD of vascular endothelial growth factor receptor 2, regulating blood vessel homeostasis. Two mutants showed constitutive kinase activity, suggesting that precise TMD orientation is mandatory for kinase activation. Nuclear magnetic resonance spectroscopy revealed that TMD helices in activated constructs were rotated by 180 relative to the interface of the wild-type conformation, confirming that ligand-mediated receptor activation indeed results from transmembrane helix rearrangement. A molecular dynamics simulation confirmed the transmembrane helix arrangement of wild-type and mutant TMDs revealed by nuclear magnetic resonance spectroscopy.
INTRODUCTION
The human genome encodes 58 receptor tyrosine kinases (RTKs) that regulate cellular activities such as growth, migration, differentiation, and survival. RTKs exist either as preformed dimers or are dimerized upon ligand binding. In both cases, ligand binding leads to conformational changes in the receptor extracellular domain (ECD), as for instance shown for type I, III, IV, and V RTKs (Schlessinger, 2003; Lemmon and Ferguson, 2007) . The structural changes in the ECD of receptor dimers subsequently instigate transmembrane signaling by reorienting the intracellular kinase domains.
We studied vascular endothelial growth factor receptors (VEGFRs) that regulate blood and lymphatic vessel development and homeostasis. Deregulated VEGFR signaling, resulting for instance from overexpression of VEGF or VEGF receptors, causes many pathologies (Koch et al., 2011) , and mutation of VEGFR-2 has been shown to be associated with juvenile hemangioma (Jinnin et al., 2008) . In addition to extensive biochemical evidence, structural analysis by single particle electron microscopy (Ruch et al., 2007) , small angle X-ray solution scattering (Kisko et al., 2011) , and X-ray crystallography (Leppä nen et al., 2013; Brozzo et al., 2012; Leppä nen et al., 2010) showed that ligand binding to VEGFR-2 promotes receptor dimerization. These studies also show that structural rearrangements in membrane-proximal VEGFR-2 ECD subdomains allosterically regulate receptor activation (Hyde et al., 2012) . High-resolution structural information is also available for other ligand-RTK complexes (Yuzawa et al., 2007; Stauber et al., 2000; Pellegrini et al., 2000; Plotnikov et al., 1999; Liu et al., 2007; Barton et al., 2006; Ogiso et al., 2002) , and X-ray crystallography of soluble kinase domain constructs revealed essential details regarding the mechanism of RTK activation (Zhang et al., 2006; Walter et al., 2007; Schubert et al., 2007) . The kinase domains of epidermal growth factor receptor (EGFR) and fibroblast growth factor receptor (FGFR), for instance, have been shown to form asymmetric dimers stabilized by interactions between the juxtamembrane domain and the upper and lower lobes of the kinase (Endres et al., 2013; Zhang et al., 2006; Bae et al., 2010; Jura et al., 2009 ). These asymmetric dimers represent the active state of these receptor kinases and have also been confirmed for the full-length EGFR (Mi et al., 2011) and FGFR (Opatowsky et al., 2014) by single particle electron microscopy.
The importance of dimerization in RTK activation is, therefore, well documented, and aberrant signaling because of mutations that lead to ligand-independent dimer formation are the cause of many diseases. For example, ligand-independent dimerization of mutant Neu receptors, an EGFR homolog, promotes tumorigenesis (Bargmann and Weinberg, 1988; Smith et al., 1996) . Such Neu mutants carried a valine-to-glutamic acid substitution in the transmembrane domain (TMD) that led to ligand-independent receptor activation (Smith et al., 1996; Gullick et al., 1992) . Similarly, mutation of the TMD of FGFR3 causes developmental disorders such as bone malformation or oncogenic transformation (Kelleher et al., 2013; Webster and Donoghue, 1996) . Based on these results, Bell et al. (2000) engineered constitutively dimerized Neu and platelet-derived growth factor receptor (PDGFR) constructs by replacing the TMD with a hydrophobic helix comprising 25 valine residues interrupted by two polar amino acids, such as glutamic acid, spaced seven amino acids apart and, therefore, located on the same face of the helix (Bell et al., 2000) . These mutations gave rise to highly stable dimers that were either active or inactive, depending on where the polar residues were located in the TMD. We applied this concept to VEGFR-2 and found that only one distinct conformation rendered the receptor constitutively active, showing that receptor dimerization is necessary, but not sufficient, for VEGFR-2 activation (Dosch and Ballmer-Hofer, 2010) .
Here we applied scanning mutagenesis to the WT TMD and correlated the activity of constructs carrying glutamic acid residues in specific positions with their structure determined by nuclear magnetic resonance (NMR) spectroscopy. Molecular dynamics (MD) simulations further support the structural and dynamic interpretation of the NMR data. Our data show that introducing two polar amino acids in distinct positions of the TMD reorients transmembrane helices and leads to stable dimer formation. Therefore, we infer that the transition between the inactive and the active dimeric state of VEGFR-2 implicates alternative dimeric TMD conformations.
RESULTS

Construction and Analysis of Constitutively Dimerized VEGFR-2 TMD Variants
To investigate the role of the TMD in VEGFR-2 signaling, we generated constitutively dimerized, ECD-truncated and fulllength receptor constructs. These constructs carried transmembrane helices with either one or two residues replaced by glutamic acid (for a summary scheme of all constructs, see Figures S1A and S1B available online) . The ECD-deleted construct carrying glutamic acid in position 769 (V769E) exhibited the highest activity ( Figure 1A , top panels), whereas the mutants I767E and L768E had a lower, but still increased activity compared with the WT TMD construct. The ECD-deleted WT TMD construct showed only 20%-30% of the activity of the activating mutants but was clearly more active than the full-length receptor in the absence of ligand, reaching about 50% of the activity of the ligand-stimulated, full-length receptor ( Figure S2A ). This shows, similar to other RTKs, that receptor dimerization and, thus, kinase activation is negatively regulated by the ECD (Dosch and Ballmer-Hofer, 2010) .
In the full-length VEGFR-2, the V769E mutation was not activating, presumably because of steric constraints by the receptor ECD that prevent the proper alignment of the two helices in the membrane. As a matter of fact, none of the single mutant TMD constructs showed ligand-independent activity ( Figure S3 ). Therefore, we generated double mutant TMD constructs carrying two glutamic acid residues spaced seven amino acids apart. In these constructs, the polar amino acids are predicted to face the same side of the TMD, giving rise to highly stable dimers. Figure 1B shows that the G770E/F777E and T771E/F778E Figure S1 shows a summary of the constructs used in this analysis. mutants had high constitutive receptor activity, which was not increased further by ligand addition. To rule out improper intracellular trafficking of such constructs and, thus, inaccessibility to extracellular ligand, we compared the membrane localization of WT and mutant TMD receptors by immunofluorescence microscopy in transfected COS-7 cells. To further demonstrate membrane localization of these mutant receptors, the cells were cotransfected with a plasmid encoding a fluorescent membrane marker. We used an enhanced green fluorescent protein (EGFP) fusion protein of the pleckstrin homology (PH) domain of phospholipase d that binds to phosphatidylinositol 4,5-bisphosphate. VEGFR-2 was labeled prior to fixation with an antibody recognizing the receptor ECD ( Figure S2B ). In agreement with our work published earlier, confocal microscopy clearly showed plasma membrane staining of both the eGFP-PH membrane marker and VEGFR-2 (Dosch and Ballmer-Hofer, 2010) .
Taken together, our data show that replacement of a single residue in the TMD by a polar amino acid in either of three positions is sufficient for activation of ECD-truncated VEGFR-2, whereas mutation of two residues in either of two positions is required for activation of full-length receptors. (A-C) Sequential and medium-range characteristic NOE-based distances (d XX (i1,i2) are shown as horizontal lines. Line thickness is proportional to the intensity of the corresponding peak in the NOESY spectrum. Meaningless contacts, i.e., contacts that do not impose any restraints on the structure, were removed by the built-in algorithm in the CYANA software (Guentert, 2003) . P_helix is the a helix propensity predicted by the TALOS+ (Shen et al., 2009 ) software on the basis of NMR chemical shifts.
NMR Analysis and 3D Structure of WT and Mutant TMDs in DPC Micelles
To analyze the effect of the identified mutations on the structural and thermodynamic properties of TMD helix-helix interactions, we determined the structures and measured the free energies of dimerization for peptides representing WT (VEGFR-2tm) and the activating mutants VEGFR-2tm769 and VEGFR-2tm770/ 777. TMD peptides were produced in vitro and inserted into membranemimetic dodecylphosphocholine (DPC) micelles. NMR chemical shifts, nuclear Overhauser effect (NOE) connectivities, and NMR relaxation data revealed that the WT peptide forms a long a helix between residues 761 and 794 (Figure 2 ). VEGFR-2tm existed in two forms, with population states depending on the detergent-to-protein ratio (for details, see Supplemental Experimental Procedures). Dilution by detergent revealed that these states represented monomers and dimers, respectively. The monomer-dimer transition was very slow, in the range of seconds, with the free energy of dimerization equal to À2.1 ± 0.2 kilocalories (kcal)/mol ( Figure 3A) . The reported free energies were obtained as described by Mineev et al. (2014) , using standard conditions corresponding to a micelle concentration of 1M. The free energy of dimerization of VEGFR-2tm was clearly lower than that observed for other RTKs, such as ErbB3 (À0.5 kcal/M), ErbB4 (À1.5 kcal/M), and FGFR3 (À1.4 kcal/M).
For the WT VEGFR-2tm peptide, we detected nine intermonomeric contacts by heteronuclei-filtered NOE spectroscopy (NOESY), which were used to calculate the 3D structure of TMD dimers. A summary of NMR data and statistics of the calculated structures is given in Table 1 . The WT structure represents a symmetric, left-handed parallel dimer with an angle between helical axes of 25 ± 1 ( Figure 5A ). , ErbB3 (Mineev et al., 2011) , and FGFR3 (Bocharov et al., 2013) . We next studied the effect of the V769E substitution on the VEGFR-2 TMD structure. The VEGFR-2tm769 peptide was inserted into DPC micelles at pH 4.5. Under these conditions, the side chains of E764 and E769 were protonated ( Figure S5 ). The NMR spectra of VEGFR-2tm769 were very similar to WT VEGFR-2tm, displaying multiple contacts between methyl groups in isoleucine, valine, and leucine residues to residual protons of the DPC methyl groups in 13 C-filtered NOESY (Figure 2) . This shows that the peptide is in a ''transmembrane'' and not in a ''surface-bound'' orientation. The side chain of the transmembrane E769 was protonated under both experimental (pH 4.5) and physiological (pH 7.0) conditions ( Figure S5 ). The secondary chemical shifts show that the a helix of VEGFR-2tm769 is present in the same section of the peptide as in the WT. Unlike the WT, the single mutant TMD formed three oligomeric states, characterized by different correlation times for rotational diffusion (Figures 4A and 4B; Figures S4A and S4B) . The samples were gradually diluted to determine peptide oligomerization and to measure the effect of the valine-to-glutamic acid substitution on oligomerization propensity. Three models for the oligomerization equilibrium were tested: monomerdimer1-dimer2, monomer-dimer-trimer, and monomer-dimertetramer. The trimerization model best fit the data obtained (Figures 3B and 3D ; Figure S4B ) with a free energy of the dimer (DG dim ) of À2.4 ± 0.2 kcal/mol and a free energy of the trimer (DG trim ) of À2.9 ± 0.2 kcal/mol. The change in the free energy of dimerization caused by the V769E mutation was insignificant, accounting for only 0.3 kcal/mol, which is within the experimental error. The population of the monomer, dimer, and trimer states depended on the peptide-to-detergent ratio. We were not able to calculate the dimer structure based on NOEs because the population of the dimeric state was low and NMR spectra were highly overlapped. The trimeric state was very stable, and, even at a 200:1 DPC:protein ratio, almost 50% of the peptide was present as trimers, precluding direct measurement of the dimer structure.
The conformation of the VEGFR-2tm769 dimer peptide was next studied by covariance analysis of N-H chemical shift changes upon dimerization of WT and mutant TMDs. We plotted the cosine of angle between vectors describing the shift of the signal from the backbone N-H group in the 1 H, 15 N transverse relaxation optimized spectroscopy-heteronuclear single quantum coherence (TROSY-HSQC) spectrum ( Figure S6 ), resulting from the dimerization of WT or mutant peptides, versus the ratios of their modules. To balance the contributions from changes in proton and nitrogen shifts, chemical shift changes were measured in hertz. Surprisingly, the vast majority of residues in the hydrophobic helix showed a good correlation for the alteration of amide proton and nitrogen chemical shifts during dimerization, and the signals moved in similar directions and by similar distances in NMR spectra upon dimerization of the WT and the V769E mutant, showing that dimer structures are very similar. The effect of the amino acid substitution on the structure of VEGFR-2tm769 was further studied in TMD trimers. A concentrated sample ($90% trimer) at a detergent-to-protein ratio of 60 was prepared, and an X-filtered NOESY spectrum was recorded. The quality of this spectrum was poor because of line broadening, which allowed the detection of only seven interhelical contacts. A single set of NMR signals corresponded to the trimeric state, and, therefore, this structure was treated as a symmetric structure where seven interhelical contacts were symmetrized to obtain 21 upper distance restraints, which were used for structure calculation. The resulting structural model is shown in Figure 5B . The trimer interface was compact and located close to the N terminus of the hydrophobic helix. The following residues were involved in helix-helix interactions: T Trimer formation may be additionally supported by stacking of aromatic side chains and by hydrogen bonds formed by the side chains of E769. However, the quality of the obtained structure was too low to determine hydrogen bonding partners for E769. The overall fold allows this residue to contact the carbonyl group of L768 and the amide group of A772. Geometric parameters of the asymmetric dimer in the trimers were similar to the previously described structures of dimeric TMDs of ErbB2 (Bocharov et al., 2008) , ErbB1/ErbB2 , and ErbB4 (Bocharov et al., 2012) . The angle between the axis of the helices was À50 ± 5 , and the carboxyl termini were separated by 20 Å in active dimers of these kinases based on 3D structures of the extracellular and kinase domains (Jura et al., 2011; Bocharov et al., 2008) . Introduction of E769 into the VEGFR-2 TMD does, therefore, not substantially enhance the propensity for dimerization, but it creates an additional surface for helix-helix interactions. We suppose that the observed trimer conformation of this mutant only exists in the VEGFR-2tm769 peptide studied here and does not exist in larger dimeric protein constructs because of steric interference of the ECDs. However, the helix-helix dimer interface observed in VEGFR-2tm769 peptide trimers may reflect the actual conformation of the TMD in the ECD-truncated V769E VEGFR-2 construct.
We next studied the structure of the VEGFR-2tm770/777 peptide carrying two glutamic acid mutations that result in activation of the full-length receptor ( Figure 1B ). Similar to the WT, two sets of signals were found in the NMR spectra, indicative of two distinct oligomeric states. The presence of the two highly polar glutamic acid residues did not disturb the transmembrane orientation of the peptide (Figure 2) , as shown by the number of NOE contacts between the methyl groups of the protein and the methylene groups of the lipid detergent phase ( Figure S7 ). The observed chemical shifts confirm that residues 761-794 form an a helix (Figure 2 ) with both transmembrane glutamic acid side chains protonated at pH 4.5 and 7.0 ( Figure S5 ). Detergent titration unambiguously revealed two conformational states: one dimeric and the other monomeric, with a free energy of dimerization of À3.2 ± 0.2 kcal/mol, which is substantially lower than the free energy observed for WT VEGFR-2tm dimerization (Figure 3C) . Thus, we conclude that VEGFR-2tm770/777 shows a significantly higher dimerization propensity than the WT. Unlike VEGFR-2tm and VEGFR-2tm769, where the dimeric state was relatively rigid, as documented by the narrow signals in the NMR spectra, the spectra of the VEGFR-2tm770/777 dimer contained a number of very broad resonances from both backbone and methyl side chain nuclei ( Figure S4C ). In particular, a large section of the backbone in the center of the a helix (amino acids 768-779) was characterized by very broad signals in 1 H, 15 N-TROSY-HSQC, whereas several signals from methyl groups in the N-terminal half of the TMD were weak ( Figure S4C ), suggesting that the backbone of the VEGFR-2tm770/777 dimers perform motions at the microsecond to millisecond time scale, such as twisting, stretching, and bending, that are accompanied by variations in the helix-helix interface. Analysis of the 13 C-filtered-NOESY NMR spectra of VEGFR2tm770/777 showed 14 intermolecular contacts, which we used to calculate the structure of TMD dimers. Not all intermolecular distance restraints could be satisfied simultaneously in a single NMR structure, as reflected by the relatively high CYANA target function and the bending of the TMD a helix. Therefore, the obtained structure is an average between various conformations of a symmetric (in the NMR time scale) parallel dimer of two a helices ( Figure 5C ). TMD helices are bent between Distance between the C termini (Å )
15.6 ± 0.6 30.7 ± 4.3 9.6 ± 0.7 a The angle between helical axes was calculated separately for N-terminal residues (761-769) and C-terminal residues (778-791) of VEGFR2tm770/777 because of the bending of the TMD a helix. The angle calculated for the whole TMD helices is given in parentheses.
residues 769-778, in agreement with line broadening of the backbone resonances ( Figure 5D ). The angle between the straight amino-and carboxy-terminal sections of the a helices is $30 , and the angle between the axes of the TMDs is, therefore, not well defined. interface and form intermolecular hydrogen bonds with the backbone of the opposing helix. However, the quality of the NMR spectra is insufficient to determine the precise partner amino acids. The helix-helix interface of the activating VEGFR2tm770/777 peptide is on the opposite side of the interface of the WT TMD, in agreement with the observed chemical shifts of the methyl groups. In particular, the d-methyl side chains of L763 in the mutant differ from those of VEGFR-2tm, which cannot be explained by the changes in the intramolecular environment resulting from the introduction of glutamic acid in positions 770 and 777 ( Figures S4A and S4C) . Moreover, the free energy of dimerization of VEGFR-2tm770/777 is insensitive to the protonation state of E764, consistent with the fact that this residue is not part of the dimerization interface ( Figures 5C and  5D ). This clearly distinguishes the activating VEGFR-2tm770/ 777 from WT VEGFR-2tm and VEGFR-2tm769. Taken together, three major aspects distinguish the VEGFR2tm770/777 dimer from the WT. Dimerization propensity is enhanced by $1 kcal/mol; dimerization occurs via a completely different interface lying on the opposite face of the helix; and the structure of this dimer is flexible, which means that TMD helices can bend and perform motions at a microsecond to millisecond time scale.
MD Simulations of WT and Mutant TMD Dimers
Analysis of the trajectories for the WT TMDs shows that this system is remarkably stable (Figure 6 , black trace), maintaining the interhelical aromatic and hydrophobic packing observed in the NMR structure with only minor fluctuations of the side chains. Interestingly, this is not the case in the simulation of the constitutively active G770E/F777E mutant, where the TMDs rapidly undergo significant structural changes from their starting conformation ( Figure 6 , red trace). Specifically, we observe that residues 770 and 777 mutated to glutamic acid engage in an interhelical ''glutamic acid zipper'' that stabilizes sliding of the TMDs by $5 Å (Figure 7 ; Movie S1). This behavior agrees with the NMR data showing that the structure of this mutant is flexible, with motions promoting changes in the dimerization interface.
We next asked whether these structural rearrangements are also possible in the WT receptor by running an MD simulation of a model of the WT TMD built on the NMR structure of the G770E/F777E mutant. The trajectories show that this system is relatively unstable and undergoes large structural rearrangements, even at relatively short time scales (Figure 6, orange  trace) . A more detailed analysis shows a rapid rearrangement in the aromatic dimerization interface because of a change in side chain conformation of F777, which is accompanied by a small rotation and sliding of the TMDs that, together, optimize the aromatic interactions. However, this seemingly minor rearrangement brings the basic residues R787, K790, and R791 in close proximity at the cytoplasmic side of the helices. As a result, the C-terminal ends of the TMDs move $15 Å apart, thereby minimizing the electrostatic repulsion between these positively charged residues (Figure 8 ; Movie S2). These large rearrangements are likely not biologically relevant for WT VEGFR-2 activation and simply result from the lack of a stabilizing mechanism of the active arrangement in the WT sequence, e.g., the glutamic acid zipper in the G770E/F777E mutant (Figure 7) or from VEGF-mediated interactions in the ECDs of the full-length WT receptor.
In the absence of NMR data for the inactivating I774E/L781E mutant, we tested the possible impact of these mutations using the WT conformation as a template for MD simulation. We found that E774 and E781 do not engage in interhelical interactions and that the hydrophobic and aromatic dimerization interfaces were maintained during simulation. Therefore, this system remains remarkably stable (Figure 6 , blue trace). We consider the high stability of this conformation, which is similar to the WT, to be the reason for the inactive phenotype of this mutant.
DISCUSSION
Transmembrane signaling by RTKs requires specific orientation of the intracellular kinase domains in active receptor dimers. Earlier studies showed that replacing small hydrophobic residues with polar amino acids in the TMD, as observed, for instance, in naturally occurring FGFR mutants, causes severe developmental pathologies, such as Crouzon syndrome, achondroplasia, or oncogenic transformation (Li et al., 2006; Webster and Donoghue, 1996; Li et al., 1997) . This results from a decrease in the free energy of dimerization by approximately 1.3 kcal/mol (Chen et al., 2010b) . Similar mutations observed in Neu receptors led to oncogenic transformation (Bargmann and Weinberg, 1988) . Based on these observations, constitutively active PDGFR-b, Neu (Bell et al., 2000) , and VEGFR-2 (Dosch and Ballmer-Hofer, 2010 ) mutants were generated that carry dimerization-promoting TMDs consisting of 23 valine and 2 glutamic acid residues. All mutants gave rise to constitutive receptor dimers, yet only a small subset showed increased ligand-independent activity, illustrating that dimerization is necessary, but not sufficient, for activation. Here we further applied scanning mutagenesis to the TMD of VEGFR-2 and determined the activity of mutant constructs and the exact spatial conformation of transmembrane helix dimers.
Kinase activity was increased in ECD-deleted VEGFR-2 compared with the full-length receptor, and this activity was increased further upon mutation of either I767, L768, or V796 to glutamic acid. However, a single polar amino acid mutation did not activate the full-length receptor, presumably because the change in the free energy of dimerization was too small to compensate for receptor repulsion by the ECD and/or negative steric interference between the TMD and the ligand-bound ECD. Taken together, this suggests that, in the absence of ligand, the ECD impedes receptor activation, maintaining receptors in an inactive conformation, as shown earlier for EGFR (Ferguson et al., 2003) and FGFR (Chen et al., 2010b) .
Therefore, we generated double glutamic acid TMD VEGFR-2 mutants. G770E/F777E and I771E/L778E displayed constitutively high ligand-independent activity. In agreement with earlier publications, this demonstrates that TMDs carrying two polar amino acids show a high dimerization propensity and, when the mutant residues are correctly positioned, activate RTKs (Bell et al., 2000; Dosch and Ballmer-Hofer, 2010) . A thermodynamic analysis of ligand binding to the ECD of VEGFR-2 showed that homotypic interactions in the membrane-proximal part of the receptor ECD destabilize ligand-receptor dimers by The NMR structure of the WT TMDs (black trace) and the model of the I774E/ L781E mutant built on this structure (blue trace) stabilize rapidly in a conformation very close to the starting structure. Thus, these arrangements of the TMDs likely represent stable local minima. However, the NMR structure of the G770E/F777E mutant (red trace) and the model of the WT sequence built on this structure (orange trace) rapidly undergo significant conformational changes that lead these systems to adopt different relative arrangements of the TMDs. 1.0À1.7 kcal/mol (Brozzo et al., 2012) . Because the V769E mutant only insignificantly decreased the free energy of dimerization, our data explain why a second polar residue is required for constitutive dimer formation of VEGFR-2. This is in full agreement with similar thermodynamic data published for FGFR3, showing that two glutamic acid residues are required to stabilize receptor dimers by the TMD (Chen et al., 2010a; Chen et al., 2010b) . Taken together, this shows that, in the absence of ligand, the ECD acts as an energy barrier that prevents ligand-independent VEGFR-2 activation. We propose that this proofreading mechanism is biologically relevant to ensure tight control of VEGF signaling.
Investigating the structural changes caused by glutamic acid mutation of RTK TMDs, Bell et al. (2000) proposed a model in which the rotational angle at which kinase subunits interact with each other governs receptor activation. To identify the TMD dimer structure required for kinase activation, we determined the structures of WT (VEGFR-2tm), single mutant (VEGFR-2tm769), and double mutant (VEGFR-2tm770/777) TMD peptides in DPC micelles applying NMR spectroscopy. We found three distinct TMD conformations. The first conformation represents the dimeric structure of the inactive WT VEGFR-2tm. VEGFR-2tm770/777, representing the activating TMD, differed from the WT dimer conformation because of rotation of the helices by 180 . This suggests that the WT dimer structure is either functionally meaningless or corresponds to an inactive, predimerized state of VEGFR-2 as, for instance, observed for EGFRs (Tao and Maruyama, 2008) . This is supported by the high stability of the WT dimer (À4.6 kcal/mol at 1M of detergent) compared with TMDs of other RTKs (Finger et al., 2009 ). In addition, MD simulation of the I774E/L781E TMD in the context of the WT dimer structure maintained the native hydrophobic and aromatic dimerization interface observed in the NMR structure (Figure 6 ). In agreement with the simulation of the active G770E/F777E mutant, E774 and E781 did not form interhelical interactions, possibly because the stable and bulky aromatic cluster formed by F777, F778, and W779 localized in between the two mutant residues. The aromatic residues sterically prevent helices from rotating and sliding into an alternative conformation and, thus, trap the helices in the inactive WT conformation. As a consequence, I774E/ L781E substitutions render VEGFR-2 constitutively inactive because of stabilization of the WT dimerization interface. Therefore, we favor the idea that this WT dimeric structure represents the conformation of the receptor in a predimerized, inactive state.
A second conformation was found for the VEGFR-2tm770/777 mutant and represents the active state of the full-length VEGFR-2, as confirmed by our biochemical analysis. The positions of the glutamic acid residues in the activating (G770E/ F777E) and the inactivating (I774E/L781E) double mutants agree well with our data published earlier using all valine TMDs of VEGFR-2 (Dosch and Ballmer-Hofer, 2010) . These conformations are stable enough to promote constitutive dimerization of VEGFR-2, and G770E/F777E provides the free energy required to compensate for steric repulsion by the receptor ECD. We further studied the molecular details of the dimerization interface of TMDs by MD simulation and modeled the conformations for interhelical interactions. Such changes occur on a nanosecond time scale (Henzler-Wildman and Kern, 2007) , so they can be captured in our simulations, which range between 120À150 ns. We found a number of interaction patterns and identified specific residues that are key to understanding the molecular determinants responsible for the phenotype of the G770E/F777E mutant. Glutamic acid residues 770 and 777 engage in a glutamic acid zipper that stabilizes the relative sliding of the TMDs by $5 Å . Such a sliding may be part of the motions suggested by the NMR data, and it would also provide an additional source of asymmetry probably required for receptor activation. We also propose that phenylalanine 777 is a key regulator of the dimerization interface because changes in side chain conformation of this residue are often related to larger-scale rearrangements of the TMD. The MD simulations thus suggest that, in addition to the rotation of the TMDs relative to each other observed in the NMR structure of the constitutively active VEGFR mutant, additional dynamic properties, such as sliding of the helices, may be important for receptor activation.
A third conformation was observed in the V769E mutant TMD and was derived from the peptide trimer structure. There is, however, no evidence that such trimers are biologically relevant and exist in the context of VEGFR-2 kinase constructs. V769E substitution has clear biological consequences for activation of the ECD-deleted VEGFR-2 construct, which is reflected neither in an enhancement of the TMD dimerization propensity nor in establishing a preferred dimeric conformation. Therefore, we propose that the observed symmetric trimer structure describes the pairwise helix-helix interactions present in constitutively active, ECD-truncated V769E VEGFR-2 dimers. The symmetric trimer structure may, however, give some insight into pairwise helix-helix interactions. This conformation may allow for optimal arrangement of the intracellular kinase domains but is The model on the left shows the active conformation of WT TMDs. This structure has the same dimerization interface as the NMR structure of the G770E/F777E double mutant ( Figure 5C ), with the exception of the contacts mediated by residues 770 and 777. On the right, MD simulations show that relocation of the interhelical aromatic-aromatic interactions mediated by F777 and F778 in the WT TMD peptide results in a small helix sliding and rotation that is further amplified into a large rearrangement of the helix C-terminal domains. These regions move 15 Å apart in the course of the simulation, to a final distance of 25 Å . See also Movie S2. Thus, the absence of the glutamic acid zipper in the WT TMDs (compare with Figure 7 ) increases structural flexibility.
incompatible with full-length constructs and does not promote the long-lived asymmetric state of activating TMDs ( Figure 5B ; Figure S8 ).
Because our structural analysis was performed with isolated micelle-embedded peptidic TMDs, our conclusions may not be unanimously applicable to the structure of full-length receptor constructs. However, because the effect of the mutations on the activity of VEGFR-2 agrees well with the observed structures of TMD dimers, we are confident that our structural analysis is also applicable to full-length receptors. In the absence of data for full-length receptor constructs, our conclusions are consistent and may provide relevant insights into the role of the TMD in VEGFR-2 activation.
Taken together, we describe here a mechanism for VEGFR-2 activation that relies on two alternative TMD conformations, WT and G770E/F777E. Comparing the structures of these TMDs shows the reorientation of the mutant by rotating both helices along the helical axis by 180
. We propose the mechanism of receptor activation summarized in Figure 9 and Figure S8 . In the absence of ligand, the ECD maintains the receptor in an inactive state, and receptor monomers exist in a dynamic monomerdimer equilibrium that is regulated by the intrinsic dimerization propensity of the WT TMD. This preformed dimer may lower the activation energy of the receptor. Ligand binding and subsequent formation of homotypic receptor ECD contacts leads to the rotation of TMD helices by 180 relative to the inactive WT conformation, presumably accompanied by sliding of the TMDs relative to each other. Auto-and transphosphorylation of tyrosine residues in the kinase and the carboxy-terminal receptor domain activates downstream signaling.
VEGF signaling is tightly controlled in vasculogenesis and angiogenesis, as demonstrated by the embryonic lethality observed upon VEGFR-2 ablation and heterozygous inactivation of VEGF-A (Shalaby et al., 1997; Shalaby et al., 1995; Ferrara et al., 1996) . So far, disease-related, constitutively active VEGFR-2 was only found in juvenile hemangiomas, resulting from missense mutations in VEGFR-2, that lead to the downregulation of the inhibitory soluble variant of VEGFR-1 (Jinnin et al., 2008) . Tight control of VEGFR-2 activity is therefore critical for vessel homeostasis and might be the consequence of the inhibitory activity exerted by the receptor ECD (Brozzo et al., 2012) , which prevents aberrant dimerization in the absence of ligand. We believe that future structural and functional information on active, inactive, and transition-state dimeric TMD conformations will open novel possibilities for the design of compounds targeting the hydrophobic milieu of the TMD.
EXPERIMENTAL PROCEDURES
Construction of Human VEGFR-2 TMD Mutants TMD mutants were cloned by introducing single or double glutamic acid mutations into the WT TMD. As described before, all constructs were tagged with an amino-terminal hemagglutinin (HA) sequence as described (Dosch and Ballmer-Hofer, 2010) . A summary of all mutants is given in Figure S1 .
Cell Culture and Kinase Activity Determination HEK293 cell cultures were maintained and kinase activities were determined as described (Dosch and Ballmer-Hofer, 2010 ) using the phospho-specific antibody pY1175 (Cell Signaling Technology) and an antibody recognizing the HA-tagged constructs (clone 3F10, Roche Diagnostics).
Cell-free Expression and Purification of VEGFR-2 TMD Peptides for NMR Analysis
The nucleic acid sequences encoding the TMD peptides for the WT VEGFR-2-tm peptide (MEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGG), the single mutant VEGFR-2-tm769 (MEKTNLEIIILE 769 G TAVIAMFFWLLLVIILRTVKRA NGG), and the double mutant VEGFR-2-tm770/777 (MEKTNLEIIILVE 770 TAVIAME 777 FWLLLVIILR TVKRANGG) (all numbering according to P35968, UniProt database, and the predicted TMD helix is underlined) were cloned into the pET20b(+) vector (Novagen) at NdeI and HindIII. The resulting plasmids were named pET20b(+)/TMD-VEGFR-2 and pET20b(+)/TMD-VEGFR-2(V 769 to glutamic acid), respectively. All proteins were synthesized in the continuous exchange cell-free expression system based on E. coli S30 extracts (Mineev et al., 2011; Bocharov et al., 2010) .
NMR Spectroscopy and Calculation of Spatial Structures
NMR spectra were acquired at 45 C on a 600-MHz Avance III spectrometer (Bruker BioSpin) equipped with pulsed-field gradient, triple resonance cryoprobes. The backbone and side chain 1 H, 13 C, and 15 N resonances were assigned using standard triple resonance techniques (Cavanagh, 2007) in the CARA software (Keller, 2004) . Triple resonance spectra were acquired in a sparse sampling mode and processed with qMDD software (Orekhov and Jaravine, 2011) . NMR spatial structures of the VEGFR-2tm and VEGFR-2tm770/777 homodimer and VEGFR-2tm769 homotrimer were calculated using the CYANA program (Guentert, 2003) . Assignment of the experimental restraints and structure calculation was performed as described previously (Bocharov et al., 2008; Bocharov et al., 2007) .
Analysis of NMR Chemical Shifts
To investigate the spatial structure of the VEGFR-2tm769 dimer, we determined NMR chemical shifts. recorded. Populations of oligomeric states, aggregation numbers for the oligomeric states of VEGFR-2tm769, and the corresponding free energies of dimerization/oligomerization equilibria were determined as described by Mineev et al. (2014) .
Molecular Dynamics Simulations
The NMR structures of the WT and G770E/F777E mutant TMDs (residues 759-795) were used as initial coordinates for MD simulations. First, the protonation state of titratable groups (except for glutamic acids, which were set as neutral as measured by NMR) were calculated using PROPKA (Olsson et al., 2000) at pH 7.0, as implemented in Protein Data Bank ID code 2PQR (Dolinsky et al., 2004) . The TMDs were then inserted in a hydrated lipid bilayer composed of approximately 130 palmitoyl-oleoyl-phosphatidyl-choline molecules and 3,700 water molecules. Ions were added to a concentration of 0.15 M NaCl, and additional ions were added to achieve charge neutrality. The system measured roughly 50 3 50 3 80 Å 3 , with a total of approximately 23,000 atoms.
This system was equilibrated as follows. First, a short (0.5-ns) simulation was performed, in which only the lipid tails were allowed to move to induce the appropriate disorder of a fluid-like bilayer. Next, the geometry of the entire system was optimized by energy minimization, followed by equilibration steps with the protein constrained (0.5 ns) and without constraints (0.5 ns). Simulations were carried out using NAMD 2.8 (Phillips et al., 2005) with the CHARMM27 all-hydrogen force field (MacKerell et al., 1998) at constant temperature (300 K) and pressure (1 atmosphere) and using a time step of 2 femtosecond. 
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